Priapism

Jump to: navigation, search

For patient information page click here

Priapism
ICD-10 N48.3
ICD-9 607.3
DiseasesDB 25148
MeSH D011317

WikiDoc Resources for Priapism

Articles

Most recent articles on Priapism

Most cited articles on Priapism

Review articles on Priapism

Articles on Priapism in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Priapism

Images of Priapism

Photos of Priapism

Podcasts & MP3s on Priapism

Videos on Priapism

Evidence Based Medicine

Cochrane Collaboration on Priapism

Bandolier on Priapism

TRIP on Priapism

Clinical Trials

Ongoing Trials on Priapism at Clinical Trials.gov

Trial results on Priapism

Clinical Trials on Priapism at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Priapism

NICE Guidance on Priapism

NHS PRODIGY Guidance

FDA on Priapism

CDC on Priapism

Books

Books on Priapism

News

Priapism in the news

Be alerted to news on Priapism

News trends on Priapism

Commentary

Blogs on Priapism

Definitions

Definitions of Priapism

Patient Resources / Community

Patient resources on Priapism

Discussion groups on Priapism

Patient Handouts on Priapism

Directions to Hospitals Treating Priapism

Risk calculators and risk factors for Priapism

Healthcare Provider Resources

Symptoms of Priapism

Causes & Risk Factors for Priapism

Diagnostic studies for Priapism

Treatment of Priapism

Continuing Medical Education (CME)

CME Programs on Priapism

International

Priapism en Espanol

Priapism en Francais

Business

Priapism in the Marketplace

Patents on Priapism

Experimental / Informatics

List of terms related to Priapism

Steven C. Campbell, M.D., Ph.D.

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Priapism is a potentially harmful medical condition in which the erect penis does not return to its flaccid state (despite the absence of both physical and psychological stimulation) within about four hours. It is often painful. Priapism is considered a medical emergency, which should receive proper treatment by a qualified medical practitioner.

The name comes from the Greek god Priapus, referring to the myth that he was ironically punished by the other gods for attempting to rape a goddess, by being given a huge (but useless) set of wooden genitals.

Causes

The causative mechanisms are poorly understood but involve complex neurological and vascular factors. Priapism may be associated with haematological disorders, especially sickle-cell disease, and other conditions such as leukemia, thalassemia, and Fabry's disease, and neurologic disorders such as spinal cord lesions and spinal cord trauma (priapism has been reported in hanging victims; see death erection).

Priapism can be caused by medications. The most common medications that cause priapism are intra-cavernous injections for treatment of erectile dysfunction (papaverine, alprostadil). Other groups reported are antihypertensives, antipsychotics (e.g chlorpromazine, clozapine), antidepressants (most notably trazodone), anticoagulants, cantharides (Spanish Fly) and recreational drugs (alcohol and cocaine). Phosphodiesterase type-5 (PDE5) inhibitors such as sildenafil (popularly Viagra), tadalafil and vardenafil have very rarely been implicated, and probably do not cause priapism. PDE-5 inhibitors have even been evaluated as preventive treatment for recurrent priapism.[1][2]

Female Priapism is a very rare disorder.

Drug Side Effect

Complications

Potential complications include ischemia, clotting of the blood retained in the penis (thrombosis), and damage to the blood vessels of the penis which may result in an impaired erectile function or impotence. In serious cases, the ischemia may result in gangrene, which could necessitate penis removal.

Treatment

Medical advice should be sought immediately for cases of erection beyond four hours. Generally, this is done at an emergency department. The therapy at this stage is to aspirate blood from the corpus cavernosum under local anaesthetic. If this is still insufficient, then intra-cavernosal injections of phenylephrine are administered. This should only be performed by a trained urologist, with the patient under constant hemodynamic monitoring, as phenylephrine can cause severe hypertension, bradycardia, tachycardia, and arrhythmia.

If aspiration fails and tumescence re-occurs, surgical shunts are next attempted. These attempt to reverse the priapic state by shunting blood from the rigid corpora cavernosa into the corpus spongiosum (which contains the glans and the urethra). Distal shunts are the first step, followed by more proximal shunts.

Distal shunts, such as the Winter's, involves puncturing the glans (the distal part of the penis) into one of the cavernosa, where the old, stagnant blood is held. This causes the blood to leave the penis and return to the circulation. This procedure can be performed by a urologist at the bedside.

Proximal shunts, such as the Quackel's, are more involved and entail operative dissection in the perineum to where the corpora meet the spongiosum, making an incision in both, and suturing both openings together.[3]

Female Priapism

Female Priapism is very rare and normally goes undiagnosed or misdiagnosed. Emergency medical attention should be sought immediately. Treatment normally consists of medicinal pain management and hospital observation.

Powerpoint Presentations

File:Priapism.ppt

Footnotes

  1. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B (2006). "Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism". Urology. 67 (5): 1043–8. doi:10.1016/j.urology.2005.11.045. PMID 16698365.
  2. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B (2006). "Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism". The journal of sexual medicine. 3 (6): 1077–84. doi:10.1111/j.1743-6109.2006.00333.x. PMID 17100941.
  3. Montague DK, Jarow J, Broderick GA; et al. (2003). "American Urological Association guideline on the management of priapism". J. Urol. 170 (4 Pt 1): 1318–24. doi:10.1097/01.ju.0000087608.07371.ca. PMID 14501756.

References


Cost Effectiveness of Priapism

| group5 = Clinical Trials Involving Priapism | list5 = Ongoing Trials on Priapism at Clinical Trials.govTrial results on PriapismClinical Trials on Priapism at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Priapism | list6 = US National Guidelines Clearinghouse on PriapismNICE Guidance on PriapismNHS PRODIGY GuidanceFDA on PriapismCDC on Priapism


| group7 = Textbook Information on Priapism | list7 = Books and Textbook Information on Priapism


| group8 = Pharmacology Resources on Priapism | list8 = AND (Dose)}} Dosing of PriapismAND (drug interactions)}} Drug interactions with PriapismAND (side effects)}} Side effects of PriapismAND (Allergy)}} Allergic reactions to PriapismAND (overdose)}} Overdose information on PriapismAND (carcinogenicity)}} Carcinogenicity information on PriapismAND (pregnancy)}} Priapism in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Priapism


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Priapism | list9 = AND (pharmacogenomics)}} Genetics of PriapismAND (pharmacogenomics)}} Pharmacogenomics of PriapismAND (proteomics)}} Proteomics of Priapism


| group10 = Newstories on Priapism | list10 = Priapism in the newsBe alerted to news on PriapismNews trends on Priapism


| group11 = Commentary on Priapism | list11 = Blogs on Priapism

| group12 = Patient Resources on Priapism | list12 = Patient resources on PriapismDiscussion groups on PriapismPatient Handouts on PriapismDirections to Hospitals Treating PriapismRisk calculators and risk factors for Priapism


| group13 = Healthcare Provider Resources on Priapism | list13 = Symptoms of PriapismCauses & Risk Factors for PriapismDiagnostic studies for PriapismTreatment of Priapism

| group14 = Continuing Medical Education (CME) Programs on Priapism | list14 = CME Programs on Priapism

| group15 = International Resources on Priapism | list15 = Priapism en EspanolPriapism en Francais

| group16 = Business Resources on Priapism | list16 = Priapism in the MarketplacePatents on Priapism

| group17 = Informatics Resources on Priapism | list17 = List of terms related to Priapism


}}



Linked-in.jpg